JH Kao

About JH Kao

JH Kao, With an exceptional h-index of 101 and a recent h-index of 56 (since 2020), a distinguished researcher at National Taiwan University, specializes in the field of Hepatology and gastroenterology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program

The Janus-faced nature of SLD in chronic hepatitis B

HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative

Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B

The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review

Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

Environment contamination and intra-hospital spread of COVID-19 in a tertiary care Hospital in Taiwan

JH Kao Information

University

Position

___

Citations(all)

50907

Citations(since 2020)

16469

Cited By

44156

hIndex(all)

101

hIndex(since 2020)

56

i10Index(all)

500

i10Index(since 2020)

288

Email

University Profile Page

Google Scholar

JH Kao Skills & Research Interests

Hepatology and gastroenterology

Top articles of JH Kao

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

2024/2/14

Jh Kao
Jh Kao

H-Index: 57

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program

Clinical and molecular hepatology

2024/1

The Janus-faced nature of SLD in chronic hepatitis B

Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association

2024/2/4

HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative

JHEP Reports

2024/1/1

Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B

Journal of Microbiology, Immunology and Infection

2024/2/1

The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review

2024/1

Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

Infectious Diseases and Therapy

2024/4/28

Environment contamination and intra-hospital spread of COVID-19 in a tertiary care Hospital in Taiwan

Journal of the Formosan Medical Association

2024/1/1

Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

JHEP Reports

2024/2/1

Statement of steatotic liver disease—A great leap toward the global standardization

Hepatology

2024/1/1

Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease

Journal of the Formosan Medical Association

2024/1/1

Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy

Clinical and Molecular Hepatology

2024/4/19

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis

Journal of the Formosan Medical Association

2024/1/1

Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct …

Journal of Gastroenterology

2024/4/13

The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan

2024/4/10

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

Hepatology International

2024/3/9

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Journal of Hepatology

2024/2/1

Comparison of CT and gadoxetic acid–enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection

Journal of the Formosan Medical Association

2024/3/1

Serum RNase L levels in patients with chronic hepatitis B virus infection

Hepatology Research

2024/3

Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving …

2024/1/23

See List of Professors in JH Kao University(National Taiwan University)

Co-Authors

academic-engine